PAM
AGRX

Panagora Asset Management’s Agile Therapeutics AGRX Stock Holding History

Panagora Asset Management’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2
Closed -$9K – 3030
2021
Q1 		$9K Hold
2
– – ﹤0.01% 2456
2020
Q4 		$12K Hold
2
– – ﹤0.01% 2270
2020
Q3 		$13K Buy
+2
New +$11.5K ﹤0.01% 2288
2019
Q4 		– Sell
-1
Closed -$2K – 2611
2019
Q3 		$2K Buy
+1
New +$2.46K ﹤0.01% 2380
2019
Q2 		– Hold
0
– – – 2581
2018
Q4 		– Sell
-46
Closed -$34K – 2554
2018
Q3 		$34K Buy
46
+36
+360% +$26.4K ﹤0.01% 2113
2018
Q2 		$10K Hold
10
– – ﹤0.01% 2269
2018
Q1 		$50K Buy
10
+2
+25% +$13.2K ﹤0.01% 2034
2017
Q4 		$45K Buy
+8
New +$74.5K ﹤0.01% 2065

Other funds holding AGRX

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return